44th Annual San Antonio Breast Cancer Symposium (SABCS)

SABCS is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease, to an international audience of academic and private physicians and researchers.

SABCS welcomes attendance by informed patient advocates representing recognized patient advocacy, education & survivor support organizations.

Annual Lynn Sage Breast Cancer Symposium

Lynn Sage Breast Cancer Symposium has been called the most valuable breast cancer meeting worldwide for the practicing clinician. For over 20 years, this multidisciplinary CME event has been bringing together leading national and international medical, surgical and radiation oncologists to present, debate and evaluate cutting-edge technology and approaches in the management of breast cancer. New options are occurring in all aspects of patient care including prevention, screening, and detection, as well as in the primary treatment modalities of surgery, radiation therapy, endocrine therapy, cytotoxic chemotherapy, novel biologic therapies as well as survivorship. This symposium focuses on the multidisciplinary cooperation that is required for the management of today’s breast cancer patient.

43rd Annual San Antonio Breast Cancer Symposium (SABCS)

SABCS is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease, to an international audience of academic and private physicians and researchers.

SABCS welcomes attendance by informed patient advocates representing recognized patient advocacy, education & survivor support organizations.

Advances in Breast Cancer Research

Make plans to join leading basic, translational, and clinical investigators at the tenth AACR Special Conference on Advances in Breast Cancer Research. This year’s program will once again address basic and translational breast cancer research not typically covered in other breast cancer conferences with a more clinical agenda. Topics will include novel model systems, inflammation and the microenvironment, genomics, heterogeneity, personalized risk and prevention, and future therapies and immuno-oncology.

Annual Lynn Sage Breast Cancer Symposium

Lynn Sage Breast Cancer Symposium has been called the most valuable breast cancer meeting worldwide for the practicing clinician. For over 20 years, this multidisciplinary CME event has been bringing together leading national and international medical, surgical and radiation oncologists to present, debate and evaluate cutting-edge technology and approaches in the management of breast cancer. New options are occurring in all aspects of patient care including prevention, screening, and detection, as well as in the primary treatment modalities of surgery, radiation therapy, endocrine therapy, cytotoxic chemotherapy, novel biologic therapies as well as survivorship. This symposium focuses on the multidisciplinary cooperation that is required for the management of today’s breast cancer patient.

12th European Breast Cancer Conference

The 12th edition of the European Breast Cancer Conference (EBCC-12) will provide a unique multidisciplinary setting for all professionals with a common interest in breast cancer to discuss, debate, inform and educate themselves about this evolving disease landscape.

This international conference is directed towards a broad audience including scientists, clinicians, patient representatives and health professionals of diverse profiles who tackle key issues facing patients throughout the continuum of the breast cancer journey.

42 Annual San Antonio Breast Cancer Symposium (SABCS)

SABCS is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease, to an international audience of academic and private physicians and researchers.

SABCS welcomes attendance by informed patient advocates representing recognized patient advocacy, education & survivor support organizations.

Komen® Oregon & SW Washington’s MBC Dinner Series

The Metastatic Breast Cancer Dinner Series provides a forum for people living with metastatic breast cancer to discuss the latest in research, treatment, and symptom management with local health experts, in a small group setting.

If you are unable to attend Dinner Series events in person, we will live-stream the presentation on our Facebook page (@KomenOregon). Individuals watching via the Facebook live video will be able to ask questions in the comments section, and they will be answered at the end of the speaker’s presentation.

Schedule:

6:15 PM – Check-in & Networking
6:45 PM – Dinner Served
7:00-8:30 PM – Presentation, followed by Q&A

Society for Immunotherapy of Cancer Annual Meeting (SITC 2019)

The Society for Immunotherapy of Cancer (SITC) Annual Meeting brings together stakeholders across the cancer immunotherapy field to advance the science, discover breakthroughs and educate the world on cancer immunotherapy.

As the largest conference solely focused on cancer immunotherapy, the Annual Meeting provides international leaders from academia, regulatory and government agencies, as well as industry representatives with a multidisciplinary educational and interactive environment focused on improving outcomes for all cancer patients.

Up ↑